Clinical Trial Update: Study of Different Doses of Irinotecan and Cisplatin for First-line Extensive-stage Small-cell Lung Cancer Treatment [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating different doses of irinotecan and cisplatin as first-line treatment for extensive-stage small cell lung cancer is in an early-stage sta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Irinotecan (Irinotecan)

Snippet

Sponsor: Guangdong Association of Clinical Trials | Conditions: Small Cell Lung Cancer | Phase 2 | Status: UNKNOWN